In the rapidly evolving landscape of therapeutic antibody research, InnoCyto delivers the gold standard in biosimilar antibodies and proteins, engineered for precision, validated for performance, and priced for accessibility.
Explore Products
Every antibody undergoes rigorous quality control with comprehensive analytical characterization including binding affinity, specificity profiling, and functional validation. Our biosimilars demonstrate equivalent performance to reference biologics.
Manufactured using state-of-the-art mammalian expression systems with stringent process controls, ensuring reproducible results you can trust across experiments and publications.
Immediate availability means no waiting for custom production. Get your research moving faster with ready-to-ship inventory and responsive technical support.
Access premium antibody reagents at a fraction of the cost of reference products – freeing your budget for broader experimental designs and deeper investigations.
HER2, Claudin18.2, DLL3, EGFR, TROP2, VEGF
CD20, CD25, CD38, TNF-α, IL-6, IL-17A, IgE
CD3, CD4, CTLA-4-Fc, LAG-3, PD1, PD-L1
NGF
GLP-1R Agonist, PCSK9
Biosimilar antibodies and recombinant proteins are versatile, cost-effective tools that support research and development across the full translational pipeline.
In drug discovery and MOA studies, biosimilar monoclonal antibodies serve as reference standards for target validation, competitive binding assays, and characterization of effector functions such as ADCC and CDC.
For biosimilarity assessment, recombinant proteins and biosimilar antibodies enable rigorous comparability testing — from binding affinity and glycan profiling to cell-based potency assays and immunogenicity evaluation.
In cell biology and immunology, recombinant cytokines and growth factors drive reproducible immune cell stimulation, receptor–ligand interaction studies, and physiologically relevant 3D culture models.
Both reagent classes are critical to diagnostic assay development, serving as capture and detection antibodies in ELISA, lateral flow, multiplex bead-based platforms, and flow cytometry calibration workflows.
| Product | Clone | Isotype | Regulatory Status | Format | Species specificity | Catalog # | Size | Price | |
|---|---|---|---|---|---|---|---|---|---|
Abatacept | N/A | RUO | Liquid | Human | 500001 500002 500003 | 1 mg 5 mg 20 mg | $400 $800 $2,200 | ||
Abciximab | Human IgG1 Fab | RUO | Liquid | Human | 500101 500102 500103 | 1 mg 5 mg 20 mg | $250 $750 $1,800 | ||
Adalimumab | Human IgG1 | RUO | Liquid | Human | 500301 500302 500303 | 1 mg 5 mg 20 mg | $190 $590 $1,800 | ||
Aflibercept | Human IgG1-Fc | RUO | Liquid | Human | 500401 500402 500403 | 1 mg 5 mg 20 mg | $500 $1,200 $3,900 | ||
Alemtuzumab | Human IgG1 | RUO | Liquid | Human | 500501 500502 500503 | 1 mg 5 mg 20 mg | $250 $750 $1,800 | ||
Atezolizuma | Human IgG1 | RUO | Liquid | Human | 500601 500602 500603 | 1 mg 5 mg 20 mg | $190 $590 $1,390 | ||
Avelumab | Human IgG1 | RUO | Liquid | Human | 500701 500702 500703 | 1 mg 5 mg 20 mg | $190 $750 $1,800 | ||
Belatacep | Human IgG1 | RUO | Liquid | Human | 500801 500802 500803 | 1 mg 5 mg 20 mg | $400 $800 $1,600 | ||
Bevacizumab | Human IgG1 | RUO | Liquid | Human | 500901 500902 500903 | 1 mg 5 mg 20 mg | $125 $400 $960 | ||
Briakinumab | Human IgG1 | RUO | Liquid | Human | 501001 501002 501003 | 1 mg 5 mg 20 mg | $250 $750 $2,000 | ||
Brolucizumab | Human IgG1 | RUO | Liquid | Human | 501101 501102 501103 | 1 mg 5 mg 20 mg | $500 $1,200 $3,900 | ||
Camrelizumab | Human IgG4 | RUO | Liquid | Human | 501201 501202 501203 | 1 mg 5 mg 20 mg | $190 $590 $1,390 | ||
Cemiplimab | Human IgG4 | RUO | Liquid | Human | 501301 501302 501303 | 1 mg 5 mg 20 mg | $190 $590 $1,390 | ||
Cetuximab | Human IgG1 | RUO | Liquid | Human | 501401 501402 501403 | 1 mg 5 mg 20 mg | $190 $500 $1,390 | ||
Clenoliximab | Human IgG4 | RUO | Liquid | Human | 501501 501502 501503 | 1 mg 5 mg 20 mg | $250 $750 $2,000 | ||
Cofetuzumab | Human IgG1 | RUO | Liquid | Human | 501601 501602 501603 | 1 mg 5 mg 20 mg | $190 $750 $1,800 | ||
Daclizumab | Human IgG1 | RUO | Liquid | Human | 501701 501702 501703 | 1 mg 5 mg 20 mg | $250 $750 $2,000 | ||
Daratumumab | Human IgG1 | RUO | Liquid | Human | 501801 501802 501803 | 1 mg 5 mg 20 mg | $175 $590 $1,390 | ||
Denosumab | Human IgG2 | RUO | Liquid | Human | 501901 501902 501903 | 1 mg 5 mg 20 mg | $190 $590 $1,390 | ||
Drozitumab | Human IgG1 | RUO | Liquid | Human | 502001 502002 502003 | 1 mg 5 mg 20 mg | $250 $750 $2,000 | ||
Dupilumab | Human IgG4 | RUO | Liquid | Human | 502101 502102 502103 | 1 mg 5 mg 20 mg | $190 $750 $1,800 | ||
Durvalumab | Human IgG1 | RUO | Liquid | Human | 502201 502202 502203 | 1 mg 5 mg 20 mg | $190 $590 $1,390 | ||
Efalizumab | Human IgG1 | RUO | Liquid | Human | 502401 502402 502403 | 1 mg 5 mg 20 mg | $250 $750 $1,800 | ||
Envafolimab | Human IgG1 | RUO | Liquid | Human | 502501 502502 502503 | 1 mg 5 mg 20 mg | $250 $650 $2,000 | ||
Epratuzumab | Human IgG1 | RUO | Liquid | Human | 502601 502602 502603 | 1 mg 5 mg 20 mg | $250 $650 $2,000 | ||
Etanercept | Human IgG1 | RUO | Liquid | Human | 502701 502702 502703 | 1 mg 5 mg 20 mg | $400 $800 $2,200 | ||
Evolocumab | Human IgG2 | RUO | Liquid | Human | 502801 502802 502803 | 1 mg 5 mg 20 mg | $190 $750 $1,800 | ||
Felvizumab | Human IgG1 | RUO | Liquid | Human | 502901 502902 502903 | 1 mg 5 mg 20 mg | $250 $750 $2,000 | ||
Galiximab | Human IgG1 | RUO | Liquid | Human | 503001 503002 503003 | 1 mg 5 mg 20 mg | $250 $750 $2,000 | ||
Gemtuzumab | Human IgG4 | RUO | Liquid | Human | 503101 503102 503103 | 1 mg 5 mg 20 mg | $250 $650 $1,800 | ||
Ifinatamab | Human IgG1 | RUO | Liquid | Human | 503201 503202 503203 | 1 mg 5 mg 20 mg | $450 $1,200 $3,900 | ||
Infliximab | Human IgG1 | RUO | Liquid | Human | 503301 503302 503303 | 1 mg 5 mg 20 mg | $125 $400 $800 | ||
Ipilimumab | Human IgG1 | RUO | Liquid | Human | 503401 503402 503403 | 1 mg 5 mg 20 mg | $190 $750 $2,000 | ||
Isatuximab | Human IgG1 | RUO | Liquid | Human | 503501 503502 503503 | 1 mg 5 mg 20 mg | $250 $650 $2,000 | ||
Matuzumab | Human IgG1 | RUO | Liquid | Human | 503601 503602 503603 | 1 mg 5 mg 20 mg | $250 $650 $2,000 | ||
Minretumomab | Human IgG1 | RUO | Liquid | Human | 503701 503702 503703 | 1 mg 5 mg 20 mg | $250 $650 $2,000 | ||
Mogamulizumab | Human IgG1 | RUO | Liquid | Human | 503801 503802 503803 | 1 mg 5 mg 20 mg | $250 $750 $2,500 | ||
Muromonab | Human IgG2 | RUO | Liquid | Human | 503901 503902 503903 | 1 mg 5 mg 20 mg | $250 $600 $1,800 | ||
Natalizumab | Human IgG4 | RUO | Liquid | Human | 504001 504002 504003 | 1 mg 5 mg 20 mg | $175 $480 $1,390 | ||
Nimotuzumab | Human IgG4 | RUO | Liquid | Human | 504101 504102 504103 | 1 mg 5 mg 20 mg | $450 $1,200 $3,900 | ||
Nivolumab | Human IgG4 | RUO | Liquid | Human | 504201 504202 504203 | 1 mg 5 mg 20 mg | $190 $590 $1,100 | ||
Obinutuzumab | Human IgG1 | RUO | Liquid | Human | 504301 504302 504303 | 1 mg 5 mg 20 mg | $250 $750 $1,800 | ||
Omalizumab | Human IgG1 | RUO | Liquid | Human | 504401 504402 504403 | 1 mg 5 mg 20 mg | $175 $590 $1,800 | ||
Palivizumab | Human IgG1 | RUO | Liquid | Human | 504501 504502 504503 | 1 mg 5 mg 20 mg | $190 $590 $1,390 | ||
Panitumumab | Human IgG2 | RUO | Liquid | Human | 504601 504602 504603 | 1 mg 5 mg 20 mg | $190 $590 $1,390 | ||
Pembrolizumab | Human IgG4 | RUO | Liquid | Human | 504701 504702 504703 | 1 mg 5 mg 20 mg | $190 $590 $1,100 | ||
Pertuzumab | Human IgG1 | RUO | Liquid | Human | 504801 504802 504803 | 1 mg 5 mg 20 mg | $190 $590 $1,800 | ||
Polatuzumab | Human IgG1 | RUO | Liquid | Human | 504901 504902 504903 | 1 mg 5 mg 20 mg | $175 $480 $1,200 | ||
Ramucirumab | Human IgG1 | RUO | Liquid | Human | 505001 505002 505003 | 1 mg 5 mg 20 mg | $190 $590 $1,390 | ||
Ranibizumab | Human IgG1 | RUO | Liquid | Human | 505101 505102 | 2 mg 10 mg | $500 $1,250 | ||
Relatlimab | Human IgG4 | RUO | Liquid | Human | 505201 505202 505203 | 1 mg 5 mg 20 mg | $175 $590 $1,800 | ||
Rituximab | Human IgG1 | RUO | Liquid | Human | 505301 505302 505303 | 1 mg 5 mg 20 mg | $190 $590 $1,800 | ||
Rovalpituzumab | Human IgG1 | RUO | Liquid | Human | 505401 505402 505403 | 1 mg 5 mg 20 mg | $190 $550 $1,390 | ||
Sacituzumab | Human IgG1 | RUO | Liquid | Human | 505501 505502 505503 | 1 mg 5 mg 20 mg | $175 $550 $1,100 | ||
Secukinumab | Human IgG1 | RUO | Liquid | Human | 505601 505602 505603 | 1 mg 5 mg 20 mg | $175 $590 $1,390 | ||
Semaglutide | NA | RUO | Liquid | Human | 505701 505702 505703 | 1 mg 5 mg 20 mg | $190 $480 $1,100 | ||
Spartalizumab | Human IgG4 | RUO | Liquid | Human | 505801 505802 505803 | 1 mg 5 mg 20 mg | $220 $650 $2,000 | ||
Tanezumab | Human IgG2 | RUO | Liquid | Human | 505901 505902 505903 | 1 mg 5 mg 20 mg | $190 $480 $1,200 | ||
Tocilizumab | Human IgG1 | RUO | Liquid | Human | 506001 506002 506003 | 1 mg 5 mg 20 mg | $190 $590 $1,800 | ||
Trastuzumab | Human IgG1 | RUO | Liquid | Human | 506101 506102 506103 | 1 mg 5 mg 20 mg | $175 $590 $1,500 | ||
Trastuzumab | Human IgG1, L234A L235A P329G (LALAPG) | RUO | Liquid | Human | 506201 | 1 mg | $650 | ||
Trastuzumab | Human IgG1, N297A | RUO | Liquid | Human | 506301 | 1 mg | $650 | ||
Tremelimumab | Human IgG2 | RUO | Liquid | Human | 506401 506402 506403 | 1 mg 5 mg 20 mg | $175 $550 $1,100 | ||
Tusamitamab | Human IgG1 | RUO | Liquid | Human | 506501 506502 506503 | 1 mg 5 mg 20 mg | $190 $590 $1,500 | ||
Ustekinumab | Human IgG1 | RUO | Liquid | Human | 506601 506602 506603 | 1 mg 5 mg 20 mg | $190 $590 $2,000 | ||
Zolbetuximab | Human IgG1 | RUO | Liquid | Human | 506701 506702 506703 | 1 mg 5 mg 20 mg | $190 $590 $1,800 | ||
Eculizumab | Human IgG4 | RUO | Liquid | Human | 506801 506802 506803 | 1 mg 5 mg 20 mg | $200 $650 $2,200 |
